Recurrent Infected Bronchiectasis in Poorly Controlled Patient Leading to Cardio Hepatorenal Syndrome

  • Maria Carlina General Practitioner, Department of Pulmonology, Wangaya General Hospital, Denpasar City, Bali, Indonesia
  • Wayan Wahyu Semara Putra Pulmonologist, Department of Pulmonology, Wangaya General Hospital, Denpasar City, Bali, Indonesia
  • Ni Made Yaniswari Pulmonologist, Department of Pulmonology, Wangaya General Hospital, Denpasar City, Bali, Indonesia

Abstract

Background: Cardio hepatorenal syndrome is a severe condition due to chronic congestive heart failure complications characterized by liver and kidney function impairment, however, this condition has a potentially reversible complication.Bronchiectasis as a chronic lung disease was a burden for the healthcare system, especially involving other organs like heart, liver, and renal function. Those conditions were complicated and created a quandary regarding the effective treatments to improve the clinical condition and reduce morbidity and mortality.


Case illustration: A 42-year-old man developed cardio hepatorenal syndrome (CHRS), which may have occurred from recurrent infected bronchiectasis that he had. His HRCT scan of the thorax with contrast showed multiple dilated bronchiwith tram track and signet ring appearance with decreased liver and renal function in laboratory findings, and probability of pulmonary hypertension (PH) and right heart failure (RHF) in echocardiography examination. The diuretic, beta-blocker, and antibiotics were given. During hospitalization, there was improvement day by day not only in his clinical condition but also in his liver and renal function. He has used oxygen as needed, and there was no longer any indication for him to be hospitalized.


Conclusion: Patients with chronic lung diseases like bronchiectasis could have decreased lung function, which developed into other connected organ functions, like heart, liver, and renal. In this case, we found reduced heart, liver, and renal function, requiring a multidisciplinary approach to improve the condition.

Keywords: Bronchiectasis, PH, RHF, cardio hepatorenal syndrome

Downloads

Download data is not yet available.

References

1. Grippi Michael, Antin-Ozerkis DE, Dela Cruz CS, Kotloff Robert., Kotton CN, Pack Allan. Fishman’s Pulmonary Diseases and Disorders Volume 1. New York; 2022.
2. Akatli AN, Ulutas H, Turkmen Samdanci E, Celik MR. Bronchiectasis: Retrospective Analysis of Clinical and Pathological Findings in a Tertiary-Care Hospital. Int J Clin Pract. 2022;2022:8773204.
3. McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Vol. 188, American Journal of Respiratory and Critical Care Medicine. 2013. p. 647–56.
4. Broaddus VC, Ernst JD, King TE, Lazarus SC, Sarmiento KF, Schnapp LM, et al. Murray & Nadel’s Textbook of Respiratory Medicine 7th Edition. 7th Edition. Broaddus VC, Ernst JD, King TE, Lazarus SC, Sarmiento KF, Schnapp LM, et al., editors. Vol. 1. Philadelphia: Elsevier; 2021. 941–960 p.
5. Rosenkranz S, Howard LS, Gomberg-Maitland M, Hoeper MM. Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure. Circulation. 2020 Feb 25;141(8):678–93.
6. Mandoli GE, Sciaccaluga C, Bandera F, Cameli P, Esposito R, D’Andrea A, et al. Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings. Vol. 26, Heart Failure Reviews. Springer; 2021. p. 263–75.
7. Cassady S, Ramani G V. Right Heart Failure in Pulmonary Hypertension. Vol. 38, Cardiology Clinics. W.B. Saunders; 2020. p. 243–55.
8. Bansal S, Prasad A, Linas S. Right Heart Failure—Unrecognized Cause of Cardiorenal Syndrome. Vol. 29, Journal of the American Society of Nephrology. American Society of Nephrology; 2018. p. 1795–8.
9. Naschitz JE, Daniel Yeshurun FICA, Shahar J, Haifa I. Cardiogenic Hepatorenal Syndrome. Angiology : The Journal of Vascular Diseases [Internet]. 1990 Nov [cited 2024 Feb 13];41(11):893–900. Available from: https://journals.sagepub.com/doi/abs/10.1177/000331979004101101
10. Poletti V, Casoni G, Chilosi M, Zompatori M. Diffuse panbronchiolitis. European Respiratory Journal. 2006 Oct;28(4):862–71.
11. Matos MJR de, Rosa MEE, Brito VM, Amaral LTW, Beraldo GL, Fonseca EKUN, et al. Differential diagnoses of acute ground-glass opacity in chest computed tomography: pictorial essay. Einstein (Sao Paulo). 2021;19:eRW5772.
12. Hardie WD, Hagood JS, Dave V, Perl AKT, Whitsett JA, Korfhagen TR, et al. Signaling pathways in the epithelial origins of pulmonary fibrosis. Vol. 9, Cell Cycle. Taylor and Francis Inc.; 2010. p. 2841–8.
13. Michael McGettrick, Peacock A. Group 3 pulmonary hypertension: Challenges and opportunities. Vol. 2020, Global Cardiology Science and Practice. HBKU Press; 2020.
14. King GG, Bates J, Berger KI, Calverley P, de Melo PL, Dellacà RL, et al. Technical standards for respiratory oscillometry. European Respiratory Journal. 2020 Feb 1;55(2).
15. Desiraju K, Agrawal A. Impulse oscillometry: The state-of-art for lung function testing. Lung India. 2016 Jul 1;33(4):410–6.
16. Kaneko KN, Finneman ZD, Avila PM, Lim JA, Sukpraprut-Braaten S. Striking Elevations in Aminotransferases in a Case of Congestive Hepatopathy Without Concurrent Hypotension. Cureus. 2022 Sep 12;
17. Katarey D, Verma S. Drug-induced liver injury. GENERAL MEDICINE Clinical Medicine. 2016;16(6):104–9.
Published
29-08-2024
Statistics
80 Views | 47 Downloads
Citatons
How to Cite
1.
Carlina M, Putra WWS, Yaniswari NM. Recurrent Infected Bronchiectasis in Poorly Controlled Patient Leading to Cardio Hepatorenal Syndrome . World Journal of Current Med and Pharm Research [Internet]. 2024Aug.29 [cited 2025May20];6(2):62-7. Available from: https://wjcmpr.com/index.php/journal/article/view/333
Section
Case Reports